Summary:
We are seeking type 2 diabetic participants who are currently taking insulin glargine (Lantus), (Basaglar), (Toujeo) for a clinical research study.
Criteria:Participation Eligibility
- 18 years of age or older
- Have a diagnosis of type 2 diabetes
- Have an HbA1c value of 7.0% to 10.5%, inclusive
- Body Mass Index (BMI) ≥ 23 kg/m²
- Additional qualification criteria exist
Qualified Participants May Receive:
Benefits
- Reimbursement may be available for time and travel
- You are provided study-related care and study medication at no cost (no health insurance required)
- You may help make a difference for yourself and for people like you